Optimization of Post-transplantation Benadamustine and Cyclophosphamide in Patients With High-risk Myeloid Malignancies and a Partially Mismatched Donor

Clinical trial NCT07238712 · RECRUITING

Trial details

NCT number: NCT07238712
Sponsor: St. Petersburg State Pavlov Medical University
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Myeloid Leukemia (AML)Chronic Myeloid Leukemia Myelodysplastic Syndromes (MDS)Myeloprolipherative Neoplsm Atypical Chronic Myeloid Leukemia

Start date: 2025-05-10
Primary completion: 2026-12-10
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.